(Q39852954)

15 September 2017

1 reference

title

Systemic amyloidosis and the skin: a review with special emphasis on clinical features and therapy (English)

1 reference

15 September 2017

1 reference

1 reference

https://api.crossref.org/works/10.1111/J.1365-2230.1979.TB01650.X

20 April 2023

author name string

S. M. Breathnach

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A394889

20 April 2023

M. M. Black

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A394889

20 April 2023

language of work or name

1 reference

1 December 1979

1 reference

full work available at URL

15 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2230.1979.tb01650.x

1 reference

https://api.crossref.org/works/10.1111/J.1365-2230.1979.TB01650.X

https://academic.oup.com/ced/article-pdf/4/4/517/48958802/ced0517.pdf

20 April 2023

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1111/J.1365-2230.1979.TB01650.X

Clinical and Experimental Dermatology

20 April 2023

published in

1 reference

15 September 2017

volume

4

1 reference

15 September 2017

issue

4

1 reference

15 September 2017

page(s)

517-536

1 reference

The Successful Treatment of Primary Amyloidosis with Intermittent Chemotherapy

15 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2230.1979.TB01650.X

A clinical analysis of the course and prognosis of forty-two patients with amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2230.1979.TB01650.X

Improved survival times in multiple myeloma treated with melphalan, prednisone, cyclophosphamide, vincristine and BCNU: M-2 protocol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2230.1979.TB01650.X

Resolution of renal amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2230.1979.TB01650.X

Treatment of "primary" renal amyloidosis with melphalan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2230.1979.TB01650.X

21 January 2018

Amyloid lymphadenopathy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2230.1979.TB01650.X

"Primary" systemic amyloidosis and myeloma. Discussion of relationship and review of 81 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2230.1979.TB01650.X

Rheumatoid arthritis with secondary amyloidosis and malabsorption syndrome. Effect of D-penicillamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2230.1979.TB01650.X

Letter: Remission in renal amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2230.1979.TB01650.X

Isolation of amyloid P component (protein AP) from normal serum as a calcium-dependent binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2230.1979.TB01650.X

Prolonged colchicine treatment in four patients with amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2230.1979.TB01650.X

Blockage of amyloid induction by colchicine in an animal model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2230.1979.TB01650.X

Amyloidosis associated with dermatomyositis and features of multiple myeloma. The progression of amyloidosis associated with corticosteroid and cytotoxic drug therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2230.1979.TB01650.X

Primary amyloidosis. Clinical, immunochemical and immunoglobulin metabolism. Studies in fifteen patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2230.1979.TB01650.X

The major proteins of human and monkey amyloid substance: Common properties including unusual N-terminal amino acid sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2230.1979.TB01650.X

The diagnosis of amyloidosis. Ancillary procedures

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2230.1979.TB01650.X

Immunoglobulins and amyloidosis. An immunologic study of sixty-two patients with biopsy-proved disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2230.1979.TB01650.X

Resolution of primary amyloidosis during chemotherapy. Studies in a patient with nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2230.1979.TB01650.X

Combination chemotherapy for primary amyloidosis reconsidered

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2230.1979.TB01650.X

Resolution of amyloidosis and plasma-cell dyscrasia with combination chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2230.1979.TB01650.X

Renal manifestations in multiple myeloma and in primary amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2230.1979.TB01650.X

X-ray diffraction studies on amyloid filaments

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2230.1979.TB01650.X

Primary systemic amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2230.1979.TB01650.X

CORTICOSTEROID THERAPY OF AMYLOID NEPHROTIC SYNDROME

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2230.1979.TB01650.X

Dimethylsulphoxide in amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2230.1979.TB01650.X

Skin involvement in generalized amyloidosis. A study of clinically involved and uninvolved skin in 50 patients with primary and secondary amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2230.1979.TB01650.X

Systemic amyloidosis with an underlying lymphoproliferative disorder report of a case in which nail involvement was a presenting feature

21 January 2018

6

1 reference

https://api.crossref.org/works/10.1111/J.1365-2230.1979.TB01650.X

The cutaneous amyloidoses. II. Systemic forms

20 April 2023

7

1 reference

https://api.crossref.org/works/10.1111/J.1365-2230.1979.TB01650.X

Bullous amyloidosis. A case report

20 April 2023

11

1 reference

https://api.crossref.org/works/10.1111/J.1365-2230.1979.TB01650.X

20 April 2023

Amyloidosis

12

1 reference

https://api.crossref.org/works/10.1111/J.1365-2230.1979.TB01650.X

Amyloidosis: current trends in its investigation

20 April 2023

13

1 reference

https://api.crossref.org/works/10.1111/J.1365-2230.1979.TB01650.X

Electron microscopic analysis of isolated amyloid fibrils from patients with primary, secondary and myeloma-associated disease. A study utilizing shadowing and negative staining techniques

20 April 2023

14

1 reference

https://api.crossref.org/works/10.1111/J.1365-2230.1979.TB01650.X

20 April 2023

Primary amyloidosis

18

1 reference

https://api.crossref.org/works/10.1111/J.1365-2230.1979.TB01650.X

Amyloid fibril proteins: proof of homology with immunoglobulin light chains by sequence analyses

20 April 2023

23

1 reference

https://api.crossref.org/works/10.1111/J.1365-2230.1979.TB01650.X

Primary amyloidosis; a clinical and pathological study

20 April 2023

28

1 reference

https://api.crossref.org/works/10.1111/J.1365-2230.1979.TB01650.X

Patterns of amyloidosis and their association with plasma-cell dyscrasia, monoclonal immunoglobulins and Bence-Jones proteins

20 April 2023

30

1 reference

https://api.crossref.org/works/10.1111/J.1365-2230.1979.TB01650.X

Renal amyloidosis: pathogenesis and therapy

20 April 2023

33

1 reference

https://api.crossref.org/works/10.1111/J.1365-2230.1979.TB01650.X

The Shoulder-Pad Sign — A Diagnostic Feature of Amyloid Arthropathy

20 April 2023

34

1 reference

https://api.crossref.org/works/10.1111/J.1365-2230.1979.TB01650.X

Treatment of experimental murine amyloidosis with dimethyl sulfoxide

20 April 2023

36

1 reference

https://api.crossref.org/works/10.1111/J.1365-2230.1979.TB01650.X

Transplantation for renal amyloidosis

20 April 2023

37

1 reference

https://api.crossref.org/works/10.1111/J.1365-2230.1979.TB01650.X

Sicca syndrome due to primary amyloidosis

20 April 2023

39

1 reference

https://api.crossref.org/works/10.1111/J.1365-2230.1979.TB01650.X

Amyloidosis: review of 236 cases

20 April 2023

41

1 reference

https://api.crossref.org/works/10.1111/J.1365-2230.1979.TB01650.X

Remission of the Nephrotic Syndrome in Renal Amyloidosis

20 April 2023

48

1 reference

https://api.crossref.org/works/10.1111/J.1365-2230.1979.TB01650.X

Spontaneous remissions of nephrotic syndrome in renal amyloidosis

20 April 2023

52

1 reference

https://api.crossref.org/works/10.1111/J.1365-2230.1979.TB01650.X

20 April 2023

Amyloidosis Palpebrarum

53

1 reference

https://api.crossref.org/works/10.1111/J.1365-2230.1979.TB01650.X

Bullous lesions of the skin and mucous membranes in primary amyloidosis

20 April 2023

54

1 reference

https://api.crossref.org/works/10.1111/J.1365-2230.1979.TB01650.X

“Amyloid Fibrils” in the Urinary Sediment

20 April 2023

55

1 reference

https://api.crossref.org/works/10.1111/J.1365-2230.1979.TB01650.X

Primary Amyloidosis Limited to Tissue of Mesodermal Origin

20 April 2023

62

1 reference

https://api.crossref.org/works/10.1111/J.1365-2230.1979.TB01650.X

The resorption of amyloid under experimental conditions

20 April 2023

63

1 reference

https://api.crossref.org/works/10.1111/J.1365-2230.1979.TB01650.X

New concepts in the pathogenesis of primary and secondary amyloid disease

20 April 2023

67

1 reference

https://api.crossref.org/works/10.1111/J.1365-2230.1979.TB01650.X

Chronic Peritoneal Dialysis in a Patient With Primary Amyloidosis, Renal Failure, and Factor X Deficiency

20 April 2023

70

1 reference

https://api.crossref.org/works/10.1111/J.1365-2230.1979.TB01650.X

Primary amyloidosis: a review

20 April 2023

71

1 reference

https://api.crossref.org/works/10.1111/J.1365-2230.1979.TB01650.X

Occurrence of amyloid deposits in the skin in secondary systemic amyloidosis

20 April 2023

73

1 reference

https://api.crossref.org/works/10.1111/J.1365-2230.1979.TB01650.X

A New Method for the Diagnosis of Systemic Amyloidosis

20 April 2023

74

1 reference

https://api.crossref.org/works/10.1111/J.1365-2230.1979.TB01650.X

Colchicine in Familial Mediterranean Fever

20 April 2023

76

1 reference

https://api.crossref.org/works/10.1111/J.1365-2230.1979.TB01650.X

20 April 2023

Identifiers

1 reference

15 September 2017

1 reference